Cigna Analysts Increase Their Forecasts After Upbeat Earnings

Cigna Corporation CI reported better-than-expected fourth-quarter results and issued a strong revenue outlook on Friday.

Cigna reported fourth-quarter 2023 sales of $ 51.15 billion, up 12% Y/Y, beating the consensus of $48.89 billion, reflecting strong growth across Evernorth Health Services and Cigna Healthcare. Cigna Healthcare’s fourth quarter adjusted sales increased 17% Y/Y to $13 billion. The adjusted EPS of $6.79, up from $5.02 a year ago, beat the Wall Street estimate of $6.53, according to data from Benzinga Pro.

Cigna declared a cash quarterly dividend of $1.40 per share to be paid on March 21, 2024, to shareholders of record as of the close of trading on March 6, 2024. This reflects a 14% increase from the 2023 cash quarterly dividend of $1.23 per share.

Cigna said it sees fiscal year 2024 revenues of at least $235 billion and adjusted EPS of at least $28.25 versus consensus of $229.24 billion and $28.26, respectively.

Cigna shares rose 5.4% to close at $323.84 on Friday.

These analysts made changes to their price targets on Cigna after the company reported quarterly results.

• Cantor Fitzgerald raised the price target on Cigna from $334 to $372. Cantor Fitzgerald analyst Sarah James upgraded the stock from Neutral to Overweight.
• RBC Capital increased Cigna price target from $327 to $354. RBC Capital analyst Frank Morgan upgraded the stock from Sector Perform to Outperform.

Read This Next: McDonald's, Caterpillar And 3 Stocks To Watch Heading Into Monday